Skip to main content
Gudarz Davar, MD, Neurology, Thousand Oaks, CA

GudarzDavarMD

Neurology Thousand Oaks, CA

Section Head, Neurodegeneration and Pain (CNS), Allergan

Are you Dr. Davar?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 32 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Gudarz Davar, MD is a board certified neurologist in Thousand Oaks, California. He is currently licensed to practice medicine in Massachusetts. He is a Section Head at Allergan.

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1989
  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1986 - 1988
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Neurology, 1983 - 1986
  • Dalhousie University Faculty of Medicine
    Dalhousie University Faculty of MedicineClass of 1982

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFO
    A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
  • Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and Abbott
    Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
  • Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS Disorders
    Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS DisordersSeptember 14th, 2021
  • Join now to see all

Grant Support

  • Endothelin 1 Induced Pain And Metastatic Prostate CancerNational Cancer Institute1999–2001
  • NMDA Receptor And Opioid Effects In Painful NeuropathyNational Institute Of Neurological Disorders And Stroke1995
  • NMDA Receptor And Opioid Effects In Painful NeuropathyNational Institute Of Neurological Disorders And Stroke1991–1994
  • GABA &Glycine In Dorsal Horn: Effect Of RhizotomyNational Institute Of Neurological Disorders And Stroke1988–1990